what does bpc 157 contain BPC-157: Experimental Peptide Creates Risk for Athletes The Hidden Risks of BPC‑157:

On the other hand, local injections which have a good amount of anecdotal support require the assistance of a medical professional

10.1113/jphysiol.2010.196998 J

Gastrointestinal symptoms, primarily nausea, vomiting, and diarrhea, are most common during the dose escalation phase and typically improve after 4 to 8 weeks at a stable dose

Clinical and neuropathological features of the arctic APP gene mutation causing early-onset Alzheimer disease

The present study aimed to investigate the relationship between obsessional thoughts and autistic traits with traits of GD by utilising a multi-item measure of obsessions as part of the full OCI-R which was developed and validated for measuring OCD symptoms in diverse clinical [18, 20] and non-clinical samples [5, 48, 60], rather than autistic traits, and by recruiting adult samples